Supplementary Material
clear cell renal cell carcinoma
CLEAR CELL RENAL CELL CARCINOMA, EVALUABLE, BEST
Supplemental Figure S1: Kaplan-Meier curves of (A) progression-free survival (PFS) and (B) overall survival (OS) for patients with clear cell renal cell carcinoma histology (N=34). Vertical lines show censored patientsClick here for additional data file.Best Response by RECIST in Evaluable Patients Treated at RP2D (Pembrolizumab 200 mg IV Q3W and Cabozantinib 60 mg PO QD) by Prior TherapyClick here for additional data file.Best Response by RECIST in Evaluable Patients Treated at the Pembrolizumab 200 mg IV Q3W and Cabozantinib 40 mg PO QD CohortClick here for additional data file.